ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Price & Overview
NYSE:ZBH • US98956P1021
Current stock price
The current stock price of ZBH is 91.03 USD. Today ZBH is up by 0.67%. In the past month the price decreased by -7.71%. In the past year, price decreased by -15.76%.
ZBH Key Statistics
- Market Cap
- 17.81B
- P/E
- 11.10
- Fwd P/E
- 10.74
- EPS (TTM)
- 8.20
- Dividend Yield
- 1.04%
ZBH Stock Performance
ZBH Stock Chart
ZBH Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ZBH. When comparing the yearly performance of all stocks, ZBH is a bad performer in the overall market: 77.39% of all stocks are doing better.
ZBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZBH. While ZBH has a great profitability rating, there are some minor concerns on its financial health.
ZBH Earnings
On February 10, 2026 ZBH reported an EPS of 2.42 and a revenue of 2.24B. The company beat EPS expectations (0% surprise) and missed revenue expectations (-0.41% surprise).
ZBH Forecast & Estimates
35 analysts have analysed ZBH and the average price target is 105.4 USD. This implies a price increase of 15.78% is expected in the next year compared to the current price of 91.03.
For the next year, analysts expect an EPS growth of 3.4% and a revenue growth 4.17% for ZBH
ZBH Groups
Sector & Classification
ZBH Financial Highlights
Over the last trailing twelve months ZBH reported a non-GAAP Earnings per Share(EPS) of 8.2. The EPS increased by 2.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.56% | ||
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| Debt/Equity | 0.55 |
ZBH Ownership
ZBH Latest News, Press Relases and Analysis
ZBH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.82 | 178.407B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.44 | 163.73B | ||
| SYK | STRYKER CORP | 21.78 | 125.748B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.73 | 93.114B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.97 | 46.511B | ||
| BDX | BECTON DICKINSON AND CO | 11.47 | 44.77B | ||
| IDXX | IDEXX LABORATORIES INC | 38.09 | 44.738B | ||
| RMD | RESMED INC | 18.15 | 32.702B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.93 | 32.44B | ||
| DXCM | DEXCOM INC | 24.53 | 24.169B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.875B | ||
| PODD | INSULET CORP | 32.02 | 14.773B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ZBH
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Company Info
IPO: 2001-07-25
ZIMMER BIOMET HOLDINGS INC
345 E Main St
Warsaw Indiana INDIANA 46580 US
CEO: Bryan Hanson
Employees: 17000
Phone: 15742676131
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
Can you describe the business of ZIMMER BIOMET HOLDINGS INC?
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Can you provide the latest stock price for ZIMMER BIOMET HOLDINGS INC?
The current stock price of ZBH is 91.03 USD. The price increased by 0.67% in the last trading session.
Does ZIMMER BIOMET HOLDINGS INC pay dividends?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a dividend yield of 1.04%. The yearly dividend amount is currently 0.96.
What is the ChartMill technical and fundamental rating of ZBH stock?
ZBH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
35 analysts have analysed ZBH and the average price target is 105.4 USD. This implies a price increase of 15.78% is expected in the next year compared to the current price of 91.03.
Can you provide the upcoming dividend date for ZIMMER BIOMET HOLDINGS INC?
The next ex-dividend date for ZIMMER BIOMET HOLDINGS INC (ZBH) is March 31, 2026.
What is ZIMMER BIOMET HOLDINGS INC worth?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a market capitalization of 17.81B USD. This makes ZBH a Large Cap stock.